Clinical Trial Update: Effects of Psyllium on Niacin Tolerability [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed to evaluate whether psyllium affects tolerability of niacin in individuals with lipid disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• Niacin (nicotinic acid)
• Psyllium (psyllium)

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Flushing, Hyperlipidemias | Phase 4 | Status: COMPLETED